Porównania kosztów leków stosowanych w terapii zachowawczej jaskry pierwotnej w Polsce w roku 2003 i 2001
Comparing evaluation of the drug costs used in conservative treatment in primary glaucoma in Poland: 2003 versus 2001
Marcin Kałużny, Bartłomiej Kałużny, Jakub J. Kałużny
Klinika Okulistyczna Akademii Medycznej w Bydgoszczy Kierownik: prof. dr hab. med. Józef Kałużny Santen Polska
Summary: Purpose: To compare the costs of drugs used daily in glaucoma therapy in Poland: 2003 versus 2001. Material and methods: Almost all antiglaucoma medications presents on Polish market were considered. Cost of one day therapy was calculated based on the drug prices on the 1st of February 2001 and 1st of July 2003. Results: Generic drug therapy (pilocarpine and timolol) is still cheap and free for patients. modern therapy is expensive and not easily available for patients in our country. Among modern drugs only Trusopt (MSD Chibret) is being refunded in 70%. Conclusions: The policy of antiglaucoma medications refundation in Poland should be changed. More of modern, effective and save drugs should be available for Polish patients.
Keywords: glaucoma, conservative treatment, cost of therapy